@Oncotelic
Therapeutics.
The deployment completes Phase 1 objectives under the companies’ joint development agreement and establishes a foundation for future pharmaceutical automation initiatives.
https://nightfoodholdings.com/article?i=166817
https://x.com/TechForce_X/status/2062247281290543163